[go: up one dir, main page]

GB9710820D0 - Immunological method - Google Patents

Immunological method

Info

Publication number
GB9710820D0
GB9710820D0 GBGB9710820.3A GB9710820A GB9710820D0 GB 9710820 D0 GB9710820 D0 GB 9710820D0 GB 9710820 A GB9710820 A GB 9710820A GB 9710820 D0 GB9710820 D0 GB 9710820D0
Authority
GB
United Kingdom
Prior art keywords
immunological method
immunological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9710820.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB9710820.3A priority Critical patent/GB9710820D0/en
Publication of GB9710820D0 publication Critical patent/GB9710820D0/en
Priority to EP98924427A priority patent/EP1017724A2/en
Priority to AU76631/98A priority patent/AU728909B2/en
Priority to PCT/GB1998/001382 priority patent/WO1998054223A2/en
Priority to CA002291004A priority patent/CA2291004A1/en
Priority to JP50035099A priority patent/JP2001517958A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/505Cells of the immune system involving T-cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
GBGB9710820.3A 1997-05-27 1997-05-27 Immunological method Pending GB9710820D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9710820.3A GB9710820D0 (en) 1997-05-27 1997-05-27 Immunological method
EP98924427A EP1017724A2 (en) 1997-05-27 1998-05-27 Immunological method
AU76631/98A AU728909B2 (en) 1997-05-27 1998-05-27 Immunological method
PCT/GB1998/001382 WO1998054223A2 (en) 1997-05-27 1998-05-27 Immunological method
CA002291004A CA2291004A1 (en) 1997-05-27 1998-05-27 Immunological method
JP50035099A JP2001517958A (en) 1997-05-27 1998-05-27 Immunological method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710820.3A GB9710820D0 (en) 1997-05-27 1997-05-27 Immunological method

Publications (1)

Publication Number Publication Date
GB9710820D0 true GB9710820D0 (en) 1997-07-23

Family

ID=10813057

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9710820.3A Pending GB9710820D0 (en) 1997-05-27 1997-05-27 Immunological method

Country Status (6)

Country Link
EP (1) EP1017724A2 (en)
JP (1) JP2001517958A (en)
AU (1) AU728909B2 (en)
CA (1) CA2291004A1 (en)
GB (1) GB9710820D0 (en)
WO (1) WO1998054223A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243327A1 (en) * 2001-03-19 2002-09-25 BioChip Technologies GmbH Suface with a pattern of cells and method for its production
GB0128153D0 (en) * 2001-11-23 2002-01-16 Bayer Ag Profiling of the immune gene repertoire
CN1842603B (en) 2003-06-27 2013-09-11 株式会社国际癌症免疫研究所 Method of selecting wt1 vaccine adaptive patient
KR101900639B1 (en) * 2007-03-05 2018-09-19 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
JP6066909B2 (en) * 2011-06-28 2017-01-25 株式会社癌免疫研究所 Peptide cancer antigen-specific T cell receptor gene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671356B1 (en) * 1991-01-09 1993-04-30 Inst Nat Sante Rech Med METHOD FOR DESCRIBING ANTIBODY (AB) DIRECTORIES AND T CELL RECEPTORS (TCR) IN THE INDIVIDUAL'S IMMUNE SYSTEM.
WO1993004695A1 (en) * 1991-08-28 1993-03-18 The Wistar Institute T cell receptor-based therapy for rheumatoid arthritis
WO1994014067A1 (en) * 1992-12-14 1994-06-23 T Cell Sciences, Inc. Diagnosis and therapy of sarcoidosis
WO1998001738A2 (en) * 1996-06-20 1998-01-15 Cornell Research Foundation, Inc. Identification of abnormalities in the expression of t and b cell antigen receptors as disease indicators

Also Published As

Publication number Publication date
AU7663198A (en) 1998-12-30
WO1998054223A3 (en) 1999-03-04
JP2001517958A (en) 2001-10-09
EP1017724A2 (en) 2000-07-12
CA2291004A1 (en) 1998-12-03
AU728909B2 (en) 2001-01-18
WO1998054223A2 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
GB9717766D0 (en) Methods
HUP0000911A3 (en) Refuse-treatment method
GB9721603D0 (en) Method
GB2345063B (en) Method
GB9706282D0 (en) Method
PL334701A1 (en) Novel method
GB9700320D0 (en) Method
GB9708918D0 (en) Methods
GB9707744D0 (en) Method
GB9707742D0 (en) Methods
ZA9810471B (en) New method
IL121534A0 (en) Immunoassay method
GB9718591D0 (en) Methods
GB9717652D0 (en) Method
GB9710820D0 (en) Immunological method
PL341657A1 (en) Deparaffining method
HUP9701386A3 (en) Immunoassay method
GB9725462D0 (en) Novel method
GB9709811D0 (en) Method
GB9701894D0 (en) Method
GB9715266D0 (en) Novel method
GB9715150D0 (en) Novel method
GB9705683D0 (en) Novel method
GB9700940D0 (en) Novel method
GB9715269D0 (en) Novel method